3rd COVID-19 Booster Shot Linked with 90% Death Reduction
Topic: Coronavirus Information
Author: Canadian Medical Association Journal
Published: 2023/01/30 - Peer-Reviewed: Yes
Contents: Summary - Introduction - Main Item - Related Topics
Synopsis: A third booster dose of a SARS-CoV-2 vaccine was associated with a 90% reduction in death in people with multiple health conditions compared to 2 doses. The study findings highlight the potential benefit of booster vaccination, specifically in vulnerable populations living with multimorbidity, and support the recent focus on older people and those with chronic conditions for future booster doses of SARS-CoV-2 vaccines beyond the first booster. The robust results support the evidence that getting boosted provides strong protection against death from COVID-19.
Introduction
Booster Vaccination with Inactivated Whole-Virus or mRNA Vaccines and Covid-19-Related Deaths Among People with Multimorbidity: A Cohort Study - Canadian Medical Association Journal.
A booster (third) dose of a SARS-CoV-2 vaccine was associated with a 90% reduction in death in people with multiple health conditions compared to 2 doses, according to a new study from Hong Kong published in Canadian Medical Association Journal (CMAJ).
Main Item
"We found a substantially reduced risk of COVID-19-related death in adults with multimorbidity who received a homologous booster dose of BNT162b2, an mRNA vaccine, or CoronaVac, an inactivated whole-virus vaccine," writes Dr. Esther Chan, Li Ka Shing Faculty of Medicine, The University of Hong Kong and Laboratory of Data Discovery for Health, Hong Kong, with coauthors. "These results support the effectiveness of booster doses of vaccines of 2 different technological platforms in lowering mortality among those with multimorbidity amid the Omicron epidemic."
As the Omicron (BA.2) variant epidemic hit Hong Kong in late 2021, the city reported the highest COVID-19 mortality rate worldwide relative to its population of 7.5 million people. Since November 11, 2021, older people, health care professionals and other priority groups were able to receive a booster dose of either the BNT162b2 mRNA (Fosun-BioNTech, equivalent to Pfizer-BioNTech outside China) or CoronaVac (Sinovac) vaccine. As of January 1, 2022, all others were eligible, resulting in more than 3 million people receiving booster doses in the first 4 months of 2022.
"Our findings suggest that this timely, massive public health measure has plausibly played a pivotal role in lowering the mortality rate amid the epidemic, especially among people living with multimorbidity," writes Francisco Lai, first author and a scientist at the Li Ka Shing Faculty of Medicine, The University of Hong Kong and Laboratory of Data Discovery for Health, Hong Kong, with coauthors.
Researchers compared data on people aged 18 years or older with 2 or more chronic conditions, such as high blood pressure, diabetes and chronic kidney disease, who received a booster (third) dose between November 11, 2021, and March 31, 2022, compared to people who received only 2 doses. The study included 120 724 recipients of the Pfizer-BioNTech vaccine (87 289 who received a booster) and 127 318 CoronaVac recipients (94 977 who received a booster). There were more deaths among CoronaVac recipients than Pfizer-BioNTech recipients.
The study findings "highlight the potential benefit from booster vaccination, specifically in vulnerable populations living with multimorbidity, and support the recent focus on older people and those with chronic conditions for future booster doses of SARS-CoV-2 vaccines beyond the first booster."
The robust results will contribute to the evidence base that getting boosted provides strong protection against death from COVID-19.
"As the data on SARS-CoV-2 vaccination records used for this study was provided by the sole operator of vaccine roll-out in Hong Kong, with a unified recording system, and with linked clinical records provided by a territory-wide public health care provider, our data should be highly reliable and representative," the authors conclude.
Attribution/Source(s):
This peer reviewed publication was selected for publishing by the editors of Disabled World due to its significant relevance to the disability community. Originally authored by Canadian Medical Association Journal, and published on 2023/01/30, the content may have been edited for style, clarity, or brevity. For further details or clarifications, Canadian Medical Association Journal can be contacted at cmaj.ca. NOTE: Disabled World does not provide any warranties or endorsements related to this article.
Explore Related Topics
1 - Unvaccinated Individuals Face Higher Rates of Mental Illness After Severe COVID-19 - A study of 18 million people finds increased mental illnesses incidence following severe COVID-19, especially in unvaccinated people.
2 - Vaccination and Boosters During Pregnancy Benefits Pregnant Women and Newborns - Receiving a COVID-19 mRNA vaccine or booster during pregnancy can benefit pregnant people and their newborn infants, according to recent findings.
3 - Acrocyanosis: Blue Legs as a Symptom of Long Covid - An case of a Long Covid patient's legs turning blue after 10 minutes of standing highlights the need for greater awareness of this symptom.
4 - SARS-CoV-2 Detected in New York City Rats - A study revealed rats are susceptible to infection with Alpha, Delta, and Omicron SARS-CoV-2 variants, and wild rats in the NYC sewer systems and elsewhere in the city have been exposed.
5 - COVID-19 a Leading Cause of Death in American Youth - Assessment of COVID-19 as the underlying cause of death among children and young people aged 0 to 19 years in America.
Page Information, Citing and Disclaimer
Disabled World is a comprehensive online resource that provides information and news related to disabilities, assistive technologies, and accessibility issues. Founded in 2004 our website covers a wide range of topics, including disability rights, healthcare, education, employment, and independent living, with the goal of supporting the disability community and their families.
Cite This Page (APA): Canadian Medical Association Journal. (2023, January 30). 3rd COVID-19 Booster Shot Linked with 90% Death Reduction. Disabled World. Retrieved October 9, 2024 from www.disabled-world.com/health/influenza/coronavirus/3rd-booster-vaccine.php
Permalink: <a href="https://www.disabled-world.com/health/influenza/coronavirus/3rd-booster-vaccine.php">3rd COVID-19 Booster Shot Linked with 90% Death Reduction</a>: A third booster dose of a SARS-CoV-2 vaccine was associated with a 90% reduction in death in people with multiple health conditions compared to 2 doses.
Disabled World provides general information only. Materials presented are never meant to substitute for qualified medical care. Any 3rd party offering or advertising does not constitute an endorsement.